Back to mobile site

More on ASND

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+193.0% Growth)
- Ratings (9.6 Score)
- Holders

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ascendis Pharma (NQ:ASND)
Delayed: 238.39 -9.3 (3.75%)
Prev. Close $247.69  
Open$249.23 
52 Wk High$21.79 
52 Wk Low$11.92 
Day High$249.23 
Day Low$237.50 
P/E N/A  
EPS$-0.07 
Volume239,384 

Friends, Peers and Foes (?): A1SN34, ASG, VRTX, BIIB, ONC (more...)

Sep 16, 2026 06:55 AM H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
Sep 15, 2026 01:57 PM Ascendis Pharma (ASND) call put ratio 1 call to 1 put a share price down 12.6%
Sep 15, 2026 06:06 AM Form 6-K Ascendis Pharma A/S For: Sep 14
Sep 15, 2026 06:06 AM Form 6-K Ascendis Pharma A/S For: Sep 14
Sep 15, 2026 03:25 AM Raymond James Downgrades Ascendis Pharma (ASND) to Outperform
Sep 14, 2026 06:00 PM Ascendis Pharma board approves $400M share repurchase program
Sep 14, 2026 06:00 PM Ascendis Announces Planned $400 Million Share Repurchase Program
Sep 14, 2026 06:00 PM Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Sep 10, 2026 06:48 AM H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
Sep 10, 2026 05:05 AM TD Cowen on Ascendis Pharma (ASND): 'encouraging'
View All Articles

Entities mentioned with ASND

View All Entities